tion is possible under microaerophilic conditions in complex culture media. Reservoir-competent animals include small mammals and certain species of birds ( Figs. 1 and 2 ). The vectors/carriers are ticks of the genus Ixodes (hard ticks) in temperate climates of the northern hemisphere: I. ricinus in Europe, I. persulcatus in north-eastern Europe and Asia, I. scapularis in north-east and mid-west USA; and I. pacificus in western USA.
The infection cycle is linked to the blood meals of the respective development stages of the ticks: larvae, nymphs and adults. About 30% of nymphal ticks in central Europe are infected with Lyme borreliae. Borrelial lymphocytoma Painless, bluish red nodule or spot, usually on the earlobe, ear helix, nipple or scrotum; more common in children (especially at the ear) than in adults.
Acrodermatitis chronica atrophicans Long standing red or blue-red lesions, usually on the extensor surfaces of the extremities. The lesions later become atrophic. Thickening of the skin and fibroid nodules on bony prominences may occur (Fig. 5) .
Neurologic manifestations Neurologic manifestations are summarized under the term Lyme neu- Direct detection of the pathogens Direct detection of borreliae by cultivation and/or nucleic amplification techniques (PCR). In controlled clinical trials, these techniques for detection of borreliae in body fluids, tissue samples, biopsies, and ticks should be limited to specialized laboratories.
Indirect detection of borrelial infection
Detection of specific antibodies should be requested only when there is sound clinical suspicion and according to diagnostic/management guidelines [6] . Results of untargeted searches have very poor predictive diagnostic value. Principle of serology: a two-tier procedure. The first tier using immunofluorescence assay, enzymelinked immunosorbent assay, chemiluminescence, etc. detects antibodies of classes IgG and IgM against B. burgdorferi sensu lato; the second tier uses immunoblotting, line-blotting or other technique with a relevant number of immunodominant Borrelia antigens to verify specificity. Seropositivity requires that both the first and the second tier are positive. Serological methods have become established as a diagnostic aid in suspected Lyme borreliosis and numerous products from different manufacturers are on the market. The principle of the two-tier procedure still pertains. The band pattern of an immunoblot together with the relative concentration of antibodies in the first tier screening test allows greater certainty in the diagnosis in clinical manifestations with a broad spectrum of differential diagnoses, such as arthritis. Nonetheless, a positive blot pattern does not indicate a definite clinical manifestation of Lyme borreliosis or an active event. Without clinical signs and symptoms there is no disease.
The best diagnostic aid provides detection of intrathecally produced specific antibodies in the cerebrospinal fluid (CSF), recorded as the CSF/serum antibody index. Together with supportive clinical symptoms and inflammatory CSF (lymphoplasmacellular pleocytosis) findings, the clinically suspected diagnosis is confirmed (Fig. 6) .
A persisting delusion is that the mere serological result "Borrelia IgM positive" requires antibiotic treatment. It should be remembered that the prevalence of serum antibodies to B. burgdorferi sensu lato in healthy adults is, e. g. in Austria, approximately 23% (20-30%) for IgG and about 18% (14-23%) for IgM.
In the following serological constellations, and in the absence of signs and symptoms of Lyme borre-liosis, antibiotic treatment should be carefully considered: a) IgM and/or IgG positive without signs of disease → no treatment. Laboratories should refrain from interpreting as "active Lyme borreliosis, antibiotic treatment required"; b) IgM and IgG negative in a patient with erythema migrans → treatment is necessary (comment: erythema migrans is a clinical diagnosis, no reason for serology); c) IgM negative, IgG positive without signs of disease: in most cases this indicates an earlier Borrelia spp. infection (borrelial IgG antibodies can persist for long periods of time) and antibiotic treatment is certainly not indicated.
Treatment with antibiotics is usually for 2-4 weeks and most patients recover uneventfully. Detailed information on the manifestations, diagnosis and treatment of Lyme borreliosis may be obtained from the references listed below [7, 8] .
The publications in this issue of the Wiener klinische Wochenschrift should be considered a stimulus to obtain further information on Lyme borreliosis, by review and original work, and on other tick-borne diseases.
